scholarly journals The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high‐throughput data

2019 ◽  
Vol 7 (5) ◽  
pp. e607 ◽  
Author(s):  
Bo Zhang ◽  
Qiong Wu ◽  
Ziheng Wang ◽  
Ran Xu ◽  
Xinyi Hu ◽  
...  
2021 ◽  
Vol 92 ◽  
pp. 107453 ◽  
Author(s):  
Feng Li ◽  
Yi Jin ◽  
Xiaolu Pei ◽  
Peiyuan Guo ◽  
Keqin Dong ◽  
...  

2021 ◽  
Vol 10 (8) ◽  
pp. 3501-3514
Author(s):  
Zan Zhang ◽  
Xueyang Xiong ◽  
Rufeng Zhang ◽  
Guoliang Xiong ◽  
Changyuan Yu ◽  
...  

2013 ◽  
Vol 13 (2) ◽  
pp. 79-80
Author(s):  
Zane Simtniece ◽  
Gatis Kirsakmens ◽  
Ilze Strumfa ◽  
Andrejs Vanags ◽  
Maris Pavars ◽  
...  

Abstract Here, we report surgical treatment of a patient presenting with pancreatic metastasis (MTS) of renal clear cell carcinoma (RCC) 11 years after nephrectomy. RCC is one of few cancers that metastasise in pancreas. Jaundice, abdominal pain or gastrointestinal bleeding can develop; however, asymptomatic MTS can be discovered by follow-up after removal of the primary tumour. The patient, 67-year-old female was radiologically diagnosed with a clinically silent mass in the pancreatic body and underwent distal pancreatic resection. The postoperative period was smooth. Four months after the surgery, there were no signs of disease progression.


Sign in / Sign up

Export Citation Format

Share Document